These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22093218)

  • 21. Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.
    Appelhans D; Klajnert-Maculewicz B; Janaszewska A; Lazniewska J; Voit B
    Chem Soc Rev; 2015 Jun; 44(12):3968-96. PubMed ID: 25519948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface-engineered dendrimers: a solution for toxicity issues.
    Mishra V; Gupta U; Jain NK
    J Biomater Sci Polym Ed; 2009; 20(2):141-66. PubMed ID: 19154667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
    Kaneshiro TL; Wang X; Lu ZR
    Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical and biomedical potential of surface engineered dendrimers.
    Satija J; Gupta U; Jain NK
    Crit Rev Ther Drug Carrier Syst; 2007; 24(3):257-306. PubMed ID: 17956215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-biocompatibility relationship of dendritic polyglycerol derivatives.
    Khandare J; Mohr A; Calderón M; Welker P; Licha K; Haag R
    Biomaterials; 2010 May; 31(15):4268-77. PubMed ID: 20206990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendrimers and their pharmaceutical applications--a review.
    Singh I; Rehni AK; Kalra R; Joshi G; Kumar M
    Pharmazie; 2008 Jul; 63(7):491-6. PubMed ID: 18717480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.
    Sebestik J; Niederhafner P; Jezek J
    Amino Acids; 2011 Feb; 40(2):301-70. PubMed ID: 21058024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomedical applications of nano-antioxidant.
    Watal G; Watal A; Rai PK; Rai DK; Sharma G; Sharma B
    Methods Mol Biol; 2013; 1028():147-51. PubMed ID: 23740118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
    Lin YL; Khanafer K; El-Sayed ME
    Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
    Yellepeddi VK; Kumar A; Palakurthi S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic core-shell systems as soft drug delivery nanocarriers.
    Lukowiak MC; Thota BN; Haag R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1327-41. PubMed ID: 25868804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
    Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
    Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dendritic systems for drug delivery applications].
    Iwamura M
    Nihon Rinsho; 2006 Feb; 64(2):231-7. PubMed ID: 16454175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent advances in the study of dendrimers-based drug delivery systems].
    Zheng C; Qiao MX; Yan L; Hu HY; Chen DW
    Yao Xue Xue Bao; 2007 Sep; 42(9):924-9. PubMed ID: 18050732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development and applications of dendrimers in biomedicine].
    Huang F; Xu L; Xu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):197-201. PubMed ID: 15762149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendrimer biocompatibility and toxicity.
    Duncan R; Izzo L
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2215-37. PubMed ID: 16297497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendrimers: Analytical characterization and applications.
    Biricova V; Laznickova A
    Bioorg Chem; 2009 Dec; 37(6):185-92. PubMed ID: 19703699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
    Stasko NA; Johnson CB; Schoenfisch MH; Johnson TA; Holmuhamedov EL
    Biomacromolecules; 2007 Dec; 8(12):3853-9. PubMed ID: 18004811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyamidoamine dendrimers with a modified Pentaerythritol core having high efficiency and low cytotoxicity as gene carriers.
    Wang Y; Kong W; Song Y; Duan Y; Wang L; Steinhoff G; Kong D; Yu Y
    Biomacromolecules; 2009 Mar; 10(3):617-22. PubMed ID: 19215068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofunctional nanosystems based on dendritic polymers.
    Quadir MA; Haag R
    J Control Release; 2012 Jul; 161(2):484-95. PubMed ID: 22245685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.